254 related articles for article (PubMed ID: 18497687)
1. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation.
Salvay DM; Rives CB; Zhang X; Chen F; Kaufman DB; Lowe WL; Shea LD
Transplantation; 2008 May; 85(10):1456-64. PubMed ID: 18497687
[TBL] [Abstract][Full Text] [Related]
2. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation.
Blomeier H; Zhang X; Rives C; Brissova M; Hughes E; Baker M; Powers AC; Kaufman DB; Shea LD; Lowe WL
Transplantation; 2006 Aug; 82(4):452-9. PubMed ID: 16926587
[TBL] [Abstract][Full Text] [Related]
3. Micro-fabricated scaffolds lead to efficient remission of diabetes in mice.
Buitinga M; Assen F; Hanegraaf M; Wieringa P; Hilderink J; Moroni L; Truckenmüller R; van Blitterswijk C; Römer GW; Carlotti F; de Koning E; Karperien M; van Apeldoorn A
Biomaterials; 2017 Aug; 135():10-22. PubMed ID: 28478326
[TBL] [Abstract][Full Text] [Related]
4. Development of an ectopic site for islet transplantation, using biodegradable scaffolds.
Dufour JM; Rajotte RV; Zimmerman M; Rezania A; Kin T; Dixon DE; Korbutt GS
Tissue Eng; 2005; 11(9-10):1323-31. PubMed ID: 16259588
[TBL] [Abstract][Full Text] [Related]
5. Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia.
Yap WT; Salvay DM; Silliman MA; Zhang X; Bannon ZG; Kaufman DB; Lowe WL; Shea LD
Tissue Eng Part A; 2013 Nov; 19(21-22):2361-72. PubMed ID: 23713524
[TBL] [Abstract][Full Text] [Related]
6. Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation.
Abualhassan N; Sapozhnikov L; Pawlick RL; Kahana M; Pepper AR; Bruni A; Gala-Lopez B; Kin T; Mitrani E; Shapiro AM
PLoS One; 2016; 11(5):e0156053. PubMed ID: 27227978
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal.
Jalili RB; Moeen Rezakhanlou A; Hosseini-Tabatabaei A; Ao Z; Warnock GL; Ghahary A
J Cell Physiol; 2011 Jul; 226(7):1813-9. PubMed ID: 21506112
[TBL] [Abstract][Full Text] [Related]
8. A bilaminated decellularized scaffold for islet transplantation: Structure, properties and functions in diabetic mice.
Wang X; Wang K; Zhang W; Qiang M; Luo Y
Biomaterials; 2017 Sep; 138():80-90. PubMed ID: 28554010
[TBL] [Abstract][Full Text] [Related]
9. Porous scaffolds support extrahepatic human islet transplantation, engraftment, and function in mice.
Gibly RF; Zhang X; Lowe WL; Shea LD
Cell Transplant; 2013; 22(5):811-9. PubMed ID: 22507300
[TBL] [Abstract][Full Text] [Related]
10. Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds.
Hlavaty KA; Gibly RF; Zhang X; Rives CB; Graham JG; Lowe WL; Luo X; Shea LD
Am J Transplant; 2014 Jul; 14(7):1523-32. PubMed ID: 24909237
[TBL] [Abstract][Full Text] [Related]
11. Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models.
Gibly RF; Zhang X; Graham ML; Hering BJ; Kaufman DB; Lowe WL; Shea LD
Biomaterials; 2011 Dec; 32(36):9677-84. PubMed ID: 21959005
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of encapsulating and microporous nondegradable hydrogel scaffold designs on islet engraftment in rodent models of diabetes.
Rios PD; Skoumal M; Liu J; Youngblood R; Kniazeva E; Garcia AJ; Shea LD
Biotechnol Bioeng; 2018 Sep; 115(9):2356-2364. PubMed ID: 29873059
[TBL] [Abstract][Full Text] [Related]
13. Localized immune tolerance from FasL-functionalized PLG scaffolds.
Skoumal M; Woodward KB; Zhao H; Wang F; Yolcu ES; Pearson RM; Hughes KR; García AJ; Shea LD; Shirwan H
Biomaterials; 2019 Feb; 192():271-281. PubMed ID: 30458362
[TBL] [Abstract][Full Text] [Related]
14. Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control.
Knight KR; Uda Y; Findlay MW; Brown DL; Cronin KJ; Jamieson E; Tai T; Keramidaris E; Penington AJ; Rophael J; Harrison LC; Morrison WA
FASEB J; 2006 Mar; 20(3):565-7. PubMed ID: 16436466
[TBL] [Abstract][Full Text] [Related]
15. RGD-containing elastin-like polypeptide improves islet transplantation outcomes in diabetic mice.
Lee KM; Kim JH; Choi ES; Kim E; Choi SK; Jeon WB
Acta Biomater; 2019 Aug; 94():351-360. PubMed ID: 31200117
[TBL] [Abstract][Full Text] [Related]
16. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ
Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753
[TBL] [Abstract][Full Text] [Related]
17. Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel.
Davis NE; Beenken-Rothkopf LN; Mirsoian A; Kojic N; Kaplan DL; Barron AE; Fontaine MJ
Biomaterials; 2012 Oct; 33(28):6691-7. PubMed ID: 22766242
[TBL] [Abstract][Full Text] [Related]
18. A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival.
Mao D; Zhu M; Zhang X; Ma R; Yang X; Ke T; Wang L; Li Z; Kong D; Li C
Acta Biomater; 2017 Sep; 59():210-220. PubMed ID: 28666883
[TBL] [Abstract][Full Text] [Related]
19. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
[TBL] [Abstract][Full Text] [Related]
20. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions.
Kheradmand T; Wang S; Gibly RF; Zhang X; Holland S; Tasch J; Graham JG; Kaufman DB; Miller SD; Shea LD; Luo X
Biomaterials; 2011 Jul; 32(20):4517-24. PubMed ID: 21458857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
